VISEN raises $150M in Series B to accelerate innovative endocrinology therapies in Greater China

VISEN Pharmaceuticals, a biotech company focused on developing and commercializing innovative endocrine drugs that addre...

January 11, 2021 | Monday | News
Prudential recommends more public-private co-operation to maximise digital healthcare in Asia

Prudential Corporation Asia (Prudential), headquartered in Hong kong, has released The Pulse of Asia -- The Healt...

January 11, 2021 | Monday | News
Chinese firm develops antigen test kit to detect new SARS-COV-2 variant

As the world watches a concerning new strain of SARS-COV-2 first identified in the United Kingdom, one global biote...

January 7, 2021 | Thursday | News
Huami expands healthcare ecosystem in the Chinese market

Huami Corp. on Jan 5, 2020 announced that it has entered into an agreement to acquired 29.99% of the outstanding shares ...

January 6, 2021 | Wednesday | News
Y-Biologics, 3D Medicines collaborate to develop novel cancer therapeutics for China

The South Korean biotech company Y-Biologics and the China-based biopharmaceutical company 3D Medicines have entere...

January 6, 2021 | Wednesday | News
Inovio adds Asian manufacturing resource to COVID-19 vaccine candidate

INOVIO, a US based biotechnology company focused on bringing to market precisely designed DNA medicines to treat and pro...

January 5, 2021 | Tuesday | News
ImmVira Group announces signing of Series C financing

ImmVira Group Company, a biotechnology platform dedicated to the development of oncolytic virus(OV) and vector type appr...

January 4, 2021 | Monday | News
Chinese firm initiates R&D of liquid nitrogen biological containers for vaccines storage

CIMC Enric Holdings has announced that its subsidiary Zhangjiagang CIMC Sanctum Cryogenic Equipment Co., Ltd recent...

January 4, 2021 | Monday | News
OUE Lippo Healthcare strengthens partnership with China Merchants Group

OUE Lippo Healthcare, based in Singapore, has announced that following the formation of the Joint Venture for ...

January 1, 2021 | Friday | News
DXY completes $500 M financing to enhance role in healthcare sector

DXY, a leading digital healthcare technology company in China, announced the completion of a $500 million fina...

December 31, 2020 | Thursday | News
Urban China to have highest cases of NSCLC over next decade, predicts GlobalData

Urban China is expected to have the highest number of diagnosed incident cases of non-small cell lung cancer (NSCLC) amo...

December 30, 2020 | Wednesday | News
China makes new inclusions in national reimbursement drug list

BeiGene, Ltd., a commercial-stage biotechnology company focused on developing and commercializing innovative medicines w...

December 28, 2020 | Monday | News
NovoNordisk's Rybelsus could be a game-changer in Type 2 Diabetes

NovoNordisk’s decision to investigate its recently launched Type 2 Diabetes (T2D) drug Rybelsus (semaglutide) in a...

December 23, 2020 | Wednesday | News
Suntrap Life Technologies discovers natural anti-COVID-19 compound

As the new coronavirus began to spread globally, Suntrap Life Technologies Ltd established a special research team. The ...

December 23, 2020 | Wednesday | News
WuXi Biologics acquires drug substance facility from Bayer

WuXi Biologics, a global company with leading open-access biologics technology platforms, and Bayer, have announced an a...

December 24, 2020 | Thursday | News
China Medical System MSCI-ESG rating upgraded to "AA"

On December 17, the largest index provider, Morgan Stanley Capital International (MSCI) updated a report on the ESG (Env...

December 22, 2020 | Tuesday | News
CUHK designs novel microrobotic diagnostic system for infectious pathogens

The Chinese University of Hong Kong (CUHK) has recently developed a fully automated, low cost and rapid microrobotic dia...

December 23, 2020 | Wednesday | News
Harbour BioMed licenses SARS-CoV-2 neutralizing Ab to AbbVie for COVID-19 treatment

China based Harbour BioMed and Utrecht University in the Netherlands have announced that they licensed to American firm ...

December 22, 2020 | Tuesday | News
Takeda sells select non-core assets to Chinese firm for $322 M

Takeda Pharmaceutical Company, headquartered in Japan, has announced that it has entered into an agreement to divest a p...

December 21, 2020 | Monday | News
Fosun Pharma inks agreement with BioNTech for COVID-19 vaccine supply in China

BioNTech and Shanghai Fosun Pharmaceutical (Group) Co, Ltd have announced an agreement to supply Mainland China with 100...

December 16, 2020 | Wednesday | News
PharmaBlock enters strategic partnership with Ascentage Pharma

PharmaBlock Sciences (Nanjing), Inc., a leading innovative chemistry product and service provider throughout the pharmac...

December 14, 2020 | Monday | News
Sinovac receives product license for 23-valent pneumonia vaccine

Sinovac Biotech Ltd, a leading provider of biopharmaceutical products in China, has announced that the China National Me...

December 11, 2020 | Friday | News
Innovative B2B medical platform Medwish gears up for global Makeshift hospitals

Hong Kong' first makeshift hospital at the Asia World-Expo, started operations on Aug 1, and had partnere...

December 9, 2020 | Wednesday | News
Sinovac secures $500M in funds for COVID-19 vaccine development

Sinovac Biotech Ltd, a leading provider of biopharmaceutical products in China, has announced that Sinovac Life Sciences...

December 8, 2020 | Tuesday | News
Antengene submits NDAs for XPOVIO (Selinexor) in multiple APAC markets

Antengene Corporation Limited, a leading innovative biopharmaceutical company dedicated to discovering, developing and c...

December 4, 2020 | Friday | News